about
Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopesChimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulationThe Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expressionOverlapping signals for translational regulation and packaging of influenza A virus segment 2Attenuation of RNA viruses by redirecting their evolution in sequence space.Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells.Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes.Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus.Comparative Profiling of Ubiquitin Proteasome System Interplay with Influenza A Virus PB2 Polymerase Protein Recapitulating Virus Evolution in Humans.Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes.DNA sequencing and phylogenetic analysis of the protease gene of ovine adenovirus 3 suggest that adenoviruses of sheep belong to two different genera.Molecular study of the quasispecies evolution of a typical pigeon paramyxovirus type 1 after serial passages in pigeons by contact.Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genesLong term context dependent genetic adaptation of the viral genetic cloudSeasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep SequencingDevelopment of a RT-nested PCR test detecting pigeon Paramyxovirus-1 directly from organs of infected animalsSera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strainsAlteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell DiseaseIsolation and Characterization of Clinical RSV Isolates in Belgium during the Winters of 2016-2018
P50
Q28294213-BE87CCFB-D347-4303-BFFF-1ABC4B6CAF09Q34277968-EC98EFE0-BE0A-4199-BF0A-742A08F07733Q35069349-D4637838-08A1-42A7-92F2-02E6C08CA2E0Q35224411-16E776F2-B823-46D0-A801-826BD0E4EAB3Q38743913-F2BD52DA-4720-40D7-A277-6F7EDC6E203AQ39772618-470FF796-E8C9-4099-A517-80F7F7F3082DQ40098336-7389BC03-7300-4E4E-BD89-FB9543BB2933Q41506910-45C1AAA5-C393-4342-B727-3E090694BA9FQ44747550-4AEB094E-A09B-4E9A-9360-330D9C5DE9BBQ45323844-8851DE58-5D28-4F61-B52D-4F99F6CDDD3AQ46498023-305C554B-6687-4A4E-81D0-5B9AAEB651A1Q47888466-B5B3F971-FCC8-4137-92E4-2C63E971F439Q48762519-DF4E4706-F200-40E6-B234-1B8E19A08D70Q56921757-4F97DB8D-9FD9-4AFD-9E76-28E08F1517EFQ57801190-00EB3A32-C29D-464E-B266-AA9D692795ECQ59133574-F70854E7-BF76-4E09-BE18-022DB7462CFDQ78409269-23410510-473E-4C28-9CA1-5F5DE230D9DDQ90016176-A0550009-8DF7-4C4A-BFCD-7E47F0DF2F33Q90629757-240CBE33-4338-4416-944A-EE57AC1A3E00Q91168401-F13AAAF4-367E-4234-BB9C-7EB080A6ADC2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cyril Barbezange
@ast
Cyril Barbezange
@en
Cyril Barbezange
@es
Cyril Barbezange
@nl
Cyril Barbezange
@sl
type
label
Cyril Barbezange
@ast
Cyril Barbezange
@en
Cyril Barbezange
@es
Cyril Barbezange
@nl
Cyril Barbezange
@sl
prefLabel
Cyril Barbezange
@ast
Cyril Barbezange
@en
Cyril Barbezange
@es
Cyril Barbezange
@nl
Cyril Barbezange
@sl
P106
P1153
57193451835
6506175885
P21
P2798
P31
P496
0000-0001-9606-2983